Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2024 Apr 1;38(4):183-189.
doi: 10.1097/BOT.0000000000002767.

Does Topical Vancomycin Powder Use in Fracture Surgery Change Bacteriology and Antibiotic Susceptibilities? An Analysis of the VANCO Trial

Manjari Joshi  1 , Robert V O'Toole  2 , Anthony R Carlini  3 , Joshua L Gary  4 , William T Obremskey  5 , Clinton K Murray  6 , Greg Gaski  7 , J Spence Reid  8 , Yasmin Degani  2 , Tara J Taylor  3 , Susan C Collins  3 , Yanjie Huang  9 , Paul S Whiting  10 , Joseph T Patterson  4 , Olivia C Lee  11 , Renan C Castillo  3 ; METRC
Affiliations
Clinical Trial

Does Topical Vancomycin Powder Use in Fracture Surgery Change Bacteriology and Antibiotic Susceptibilities? An Analysis of the VANCO Trial

Manjari Joshi et al. J Orthop Trauma. .

Abstract

Objective: To determine whether intrawound vancomycin changes the bacteriology of surgical site infection pathogens and investigate the emergence of antibiotic-resistant pathogens.

Design: Secondary analysis of phase III, prospective, randomized clinical trial.

Setting: Thirty-six US trauma centers.

Patient selection criteria: Patients who became infected after fixation of tibial plateau or pilon fracture.

Outcome measures and comparisons: Pathogen types and bacterial susceptibilities as determined from routine clinical culture in the operating room.

Results: Seventy-four patients were studied who were 67.5% male with a mean age of 48.6 years. A lower proportion of gram-positive cocci was observed in the vancomycin powder compared with the standard-of-care group (3.7% vs. 8.0%, P = 0.01). Methicillin-resistant Staphylococcus aureus infection incidence was comparable in both the vancomycin powder and the standard-of-care groups, but rates of methicillin-susceptible S. aureus infections were lower in the treatment group (1.4% vs. 4.8%, P = 0.01). The incidence of coagulase-negative Staphylococci and gram-negative rod infections were similar in both groups. There was no significant difference in susceptibilities between groups in rates of vancomycin-resistant enterococcus.

Conclusions: Topical vancomycin powder decreases the likelihood of gram-positive infections consistent with the biologic activity of vancomycin. Fewer methicillin-susceptible S. aureus and coagulase-negative Staphylococci infections were observed in the group treated with vancomycin powder. An effect of vancomycin powder on methicillin-resistant S. aureus infection risk was not detected given the low incidence in both the intrawound vancomycin and the standard-of-care groups. There was no emergence of gram-negative rod infections or increased resistance patterns observed. Use of topical vancomycin powder does not seem to produce infections in these patients with greater antibiotic resistance than would have occurred without its use.

Level of evidence: Therapeutic Level II. See Instructions for Authors for a complete description of levels of evidence.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflict of interest.

References

    1. Torbert JT, Joshi M, Moraff A, et al. Current bacterial speciation and antibiotic resistance in deep infections after operative fixation of fractures. J Orthop Trauma. 2015;29:7–17.
    1. Montalvo RN, Natoli RM, O'Hara NN, et al. Variations in the organisms causing deep surgical site infections in fracture patients at a level I trauma center (2006-2015). J Orthop Trauma. 2018;32:e475–e481.
    1. Movassaghi K, Wang JC, Gettleman BS, et al. Systematic review and meta-analysis of intrawound vancomycin in total hip and total knee arthroplasty: a continued call for a prospective randomized trial. J Arthroplasty. 2022;37:1405–1415.e1.
    1. Luo H, Ren Y, Su Y, et al. Intraoperative vancomycin powder to reduce surgical site infections after posterior spine surgery: a systematic review and meta-analysis. EFORT Open Rev. 2022;7:109–121.
    1. Fleischman AN, Austin MS. Local intra-wound administration of powdered antibiotics in orthopaedic surgery. J Bone Joint Infect. 2017;2:23–28.

Publication types

MeSH terms